Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib effectively reduces hair loss in children with alopecia areata but may cause mild side effects and relapses.

Alopecia areata has a high chance of persisting and relapsing, with a significant risk of total hair loss, especially if it starts in childhood.

Spironolactone helps reduce fluid in the eye in Central Serous Chorioretinopathy, but doesn't improve vision and recurrence is common.

Spinal fMRI can help understand brainstem and spinal cord function, especially in spinal cord injury patients.

The document discusses challenges in eye care, including treating melanoma before macular hole repair, bloody tears resolved by blood pressure control, eyelash regrowth in hair-pulling disorder with medication, a non-invasive method to detect eyelash mites, and the psychological factors affecting contact lens comfort.

Stress keratins are expressed less in diseased skin and are linked to differentiation, inflammation, and immunity.

Triboelectric nanogenerators can power wearable medical devices for long-term self-treatment and monitoring.

Lower Gas6 and sAxl levels are linked to hair loss in COVID-19 survivors.

Pili torti is a rare condition where hair is twisted and breaks easily, often linked to genetic disorders or other health issues.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Bimatoprost is more effective than sweet almond oil for enhancing eyebrow growth.

A 15-year-old girl has a skin condition causing blisters on her feet, likely inherited from her family.

Steroid use can cause a rare eye condition called central serous retinopathy, which can lead to permanent vision damage.

Tofacitinib is a promising treatment for severe alopecia areata, with many patients experiencing complete or partial hair regrowth.

Bimatoprost increases hair growth in mice without breaking down into other substances.

Alopecia areata is likely caused by a combination of genetic factors and immune system dysfunction, and may represent different diseases with various causes.

Some treatments can help with hair regrowth in alopecia areata, but results vary and long-term use is often needed without changing the disease's outcome.

The document concludes that using a phototrichogram with a protractor and tapeline is a reliable and noninvasive way to measure hair loss.

Some oral medications may help treat central serous chorioretinopathy, especially eplerenone, but more research is needed.

New scaffold materials help heal severe skin wounds and improve skin regeneration.

Calcipotriol may effectively treat hair loss in alopecia areata, working better in children than adults.

Finasteride reduces Hidradenitis Suppurativa flare-ups in children and teens, but long-term safety is unknown.

Rubbing calcipotriol on the skin works better than taking vitamin D pills for treating mild to moderate alopecia areata.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

There may be a connection between Frontal Fibrosing Alopecia and Lichen Planus Pigmentosus, and more research is needed to confirm this.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Rituximab leads to longer remission and fewer side effects than cyclophosphamide.

Topical 0.1% tacrolimus significantly improved ear infections in cats.

Gonadal hormones significantly affect the severity of alopecia areata in mice.

High levels of the protein Flightless I worsen ulcerative colitis symptoms in mice.